{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:47:55Z","timestamp":1761562075567},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01 CA-111295"],"award-info":[{"award-number":["U01 CA-111295"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jtoelsevier.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jtho.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T02:47:13Z","timestamp":1456022833000},"page":"900-909","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"11","author":[{"given":"Harvey I.","family":"Pass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra","family":"Goparaju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo","family":"Espin-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Donington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devalben","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Feld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirish","family":"Gadgeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Chachoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Leighl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Sound","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2016.02.006_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the International Association for the Study of Lung Cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/JTO.0000000000000181","article-title":"Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee","volume":"9","author":"Pass","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1373\/clinchem.2008.117465","article-title":"New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs","volume":"55","author":"Anborgh","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtho.2016.02.006_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bjc.2012.345","article-title":"Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response","volume":"107","author":"Thoms","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2016.02.006_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/gut.2006.109868","article-title":"Elevated plasma osteopontin associated with gastric cancer development, invasion and survival","volume":"56","author":"Wu","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jtho.2016.02.006_bib7","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1200\/JCO.2006.06.8627","article-title":"Plasma osteopontin is an independent prognostic marker for head and neck cancers","volume":"24","author":"Petrik","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib8","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/1078-0432.CCR-05-2354","article-title":"Serial plasma osteopontin levels have prognostic value in metastatic breast cancer","volume":"12","author":"Bramwell","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.006_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":"Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5301\/JBM.2011.8614","article-title":"Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide","volume":"26","author":"Dipalma","year":"2011","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.jtho.2016.02.006_bib11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.006_bib12","doi-asserted-by":"crossref","first-page":"e26515","DOI":"10.1371\/journal.pone.0026515","article-title":"Auto-antibodies to beta-F1-ATPase and vimentin in malignant mesothelioma","volume":"6","author":"Creaney","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2016.02.006_bib13","first-page":"190","article-title":"Fibulin-3 as a biomarker for pleural mesothelioma","volume":"368","author":"Pass","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2016.02.006_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cllc.2012.03.011","article-title":"Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board","volume":"14","author":"Kao","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2016.02.006_bib15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"13","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2016.02.006_bib17","series-title":"Modeling Survival Data:\u00a0Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.jtho.2016.02.006_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield\u00a0of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jtho.2016.02.006_bib19","first-page":"429","article-title":"Regression using fractional polynomials of continous covariatges parsimonious parametric modelling","volume":"43","author":"Royston","year":"2015","journal-title":"J\u00a0Royal Stat Soc"},{"key":"10.1016\/j.jtho.2016.02.006_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1467-985X.00122","article-title":"Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials","volume":"162","author":"Sauerbrei","year":"1999","journal-title":"J\u00a0Royal Stat Soc"},{"key":"10.1016\/j.jtho.2016.02.006_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluation assumptions and adequacy, and measuring and reducing errors","volume":"5","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jtho.2016.02.006_bib22","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.jtho.2016.02.006_bib23","series-title":"S: An Interactive Environment for Data Analysis and Graphics","author":"Becker","year":"1984"},{"key":"10.1016\/j.jtho.2016.02.006_bib24","unstructured":"Gibhub. Hmisc: Harrell Micscellaneous. https:\/\/github.com\/harrelfe\/Hmisc. Accessed March 7, 2016."},{"key":"10.1016\/j.jtho.2016.02.006_bib25","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/bjc.2013.504","article-title":"Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma","volume":"109","author":"Meniawy","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2016.02.006_bib26","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1158\/1078-0432.CCR-12-2117","article-title":"Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma","volume":"19","author":"De","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.006_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1158\/1078-0432.CCR-0607-3","article-title":"Gene expression profiles predict survival and progression of pleural mesothelioma","volume":"10","author":"Pass","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.006_bib28","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Lopez-Rios","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.006_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A\u00a0nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2016.02.006_bib30","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.006_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1378\/chest.11-0129","article-title":"The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor","volume":"141","author":"Hollevoet","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2016.02.006_bib32","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","article-title":"Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma","volume":"6","author":"Cristaudo","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/JTO.0b013e318187491c","article-title":"Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer","volume":"3","author":"Schneider","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib34","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","article-title":"Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment","volume":"13","author":"Grigoriu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2016.02.006_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/bjc.2015.9","article-title":"Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study","volume":"112","author":"Ghanim","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2016.02.006_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1309\/TWCQV536WWRNEU51","article-title":"Prognostic role of osteopontin expression in malignant pleural mesothelioma","volume":"130","author":"Cappia","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtho.2016.02.006_bib37","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","article-title":"Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma","volume":"6","author":"Hollevoet","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib38","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2016.02.006_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A\u00a0feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the \u201cSMART\u201d approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2016.02.006_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.39542.610000.3A","article-title":"Predicting citations: Validating prediction models 10","volume":"336","author":"Steyerberg","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jtho.2016.02.006_bib41","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bjc.2015.286","article-title":"Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis","volume":"113","author":"Kirschner","year":"2015","journal-title":"Br J Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086416004081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086416004081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T20:57:18Z","timestamp":1567630638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086416004081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1556086416004081"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2016.02.006","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}